Aller au contenu principal
Profil bibliographique

Juhani Ruuskanen

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

160Publications signalées
7765Citations signalées
0Affiliations récentes

Les domaines associés

Air Quality and Health ImpactsAir Quality Monitoring and ForecastingToxic Organic Pollutants ImpactVehicle emissions and performanceAtmospheric chemistry and aerosols

Les publications récentes

2025 article OpenAlex

Mechanical Thrombectomy Access in Africa: A Mission Thrombectomy Study Subanalysis

Gabriela Alejo, Sidarrth Prasad, Fadar Oliver Otite, Erica Jones et autres

troke burden and mortality may be higher in Africa compared with other world regions.1 The large vessel occlusion stroke subtype portends the highest mortality risk but mechanical thrombectomy (MT) can mitigate this. MT utilization is nearly 500-fold lower in low-/middle-income countries compared …

us, Cameroun (code pays fourni par la source)

2 citations Stroke
Accès ouvert 2024 article OpenAlex

Air pollution and PEF measurements of children in the vicinity of a steel works

Kati Oravisjärvi, Arja Rautio, Juhani Ruuskanen, Pekka Tiittanen et autres

The effects of short-term changes in particulate air pollution on the respiratory health of symptomatic children living near a steel works at Raahe, Finland, were assessed to determine whether particulate air pollution is associated with adverse respiratory effects, and whether specific sources …

3 citations Työväentutkimus Vuosikirja
Accès ouvert 2024 article OpenAlex

Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes

Eric E. Smith, Ashkan Shoamanesh, Lizhen Xu, Laura Heenan et autres

BACKGROUND: Exploratory analysis of the phase 2 PACIFIC-Stroke (Program of Anticoagulation via Inhibition of FXIa by the Oral Compound BAY 2433334-Non-Cardioembolic Stroke) randomized trial suggested that asundexian, an oral factor XIa inhibitor, prevents recurrent stroke and transient ischemic attacks in patients with …

ca, us, tw, be, ch, it, es, jp, bg, au, fr, de (code pays fourni par la source)

13 citations Stroke
Accès ouvert 2018 article OpenAlex

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados, Mukul Sharma et autres

BACKGROUND: Patent foramen ovale (PFO) is a contributor to embolic stroke of undetermined source (ESUS). Subgroup analyses from previous studies suggest that anticoagulation could reduce recurrent stroke compared with antiplatelet therapy. We hypothesised that anticoagulant treatment with rivaroxaban, an oral factor Xa …

us, ca, cl, gb, de, ar, ch, pt, se (code pays fourni par la source)

181 citations The Lancet Neurology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.